Literature DB >> 26221226

Lung morphometry changes in prevention of airway remodeling by protocatechuic aldehyde in asthmatic mice.

Jiankai Zhang1, Mulan Ma2, Dongyun Qin3, Jianping Huang4, Xiaojun Cui1, Yongfu Wu3, Huiling Yang3, Hui Fu3, Cui Liao5.   

Abstract

Airway remodeling can lead to irreversible airflow obstruction and persistent airway hyper-responsiveness, which is the pathological basis of refractory asthma. To investigate the preventive effect of protocatechuic aldehyde on airway remodeling in asthmatic mice by lung morphometry methods. BALB/c mice were used to establish model of airway remodeling by ovalbumin (OVA) inhalation. Bronchoalveolar lavage fluid (BALF) were collected for eosinophils (EOS) count and detection of interleukin 4 (IL-4), interleukin-13 (IL-13) and interferon (IFN-γ) content. The left lung pathological sections were performed HE, AB-PAS and Masson staining. The epithelial lamina thickness of the left main bronchus (Re), the smooth muscle layer thickness (Rm), the number of goblet cells and goblet cell area percentage (%Ac) and gas side of the road and vascular collagen deposition (%Aco, %Avc) situation were measured. Protocatechuic aldehyde gavage made the reduction of BALF EOS count. IL-4 and IL-13 levels also decreased, while the IFN-γ level increased. The left main bronchus Re, Rm, goblet cell count, Ac% and Aco% and Avc% reduced. Protocatechuic aldehyde can significantly control airway inflammation and prevent airway remodeling.

Entities:  

Keywords:  Protocatechuic aldehyde; airway remodeling; asthma; lung morphometry

Year:  2015        PMID: 26221226      PMCID: PMC4509171     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  34 in total

1.  Salvia miltiorrhiza injection on pulmonary heart disease: a systematic review and meta-analysis.

Authors:  Yu Liu; Yuhong Huang; Caiyan Zhao; Xiude Qin; Qinghua Zhu; Sheng Chen; Jinglai Qu
Journal:  Am J Chin Med       Date:  2014       Impact factor: 4.667

2.  Protocatechuic aldehyde inhibits migration and proliferation of vascular smooth muscle cells and intravascular thrombosis.

Authors:  Chang Yoon Moon; Cheol Ryong Ku; Yoon Hee Cho; Eun Jig Lee
Journal:  Biochem Biophys Res Commun       Date:  2012-05-26       Impact factor: 3.575

3.  Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4.

Authors:  A Trautmann; G Krohne; E B Bröcker; C E Klein
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

4.  Modeling the role of TGF-β in regulation of the Th17 phenotype in the LPS-driven immune system.

Authors:  Seongwon Lee; Hyung Ju Hwang; Yangjin Kim
Journal:  Bull Math Biol       Date:  2014-03-08       Impact factor: 1.758

Review 5.  Chemokines in asthma: cooperative interaction between chemokines and IL-13.

Authors:  Nives Zimmermann; Gurjit Khurana Hershey; Paul S Foster; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

6.  A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.

Authors:  William R Henderson; Li-Ou Tang; Shi-Jye Chu; Shih-Ming Tsao; Gertrude K S Chiang; Falaah Jones; Mechthild Jonas; Chong Pae; Huaijing Wang; Emil Y Chi
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

Review 7.  Airway remodeling: lessons from animal models.

Authors:  David Ramos-Barbón; Mara S Ludwig; James G Martin
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

8.  Prolonged allergen challenge in mice leads to persistent airway remodelling.

Authors:  S J McMillan; C M Lloyd
Journal:  Clin Exp Allergy       Date:  2004-03       Impact factor: 5.018

9.  Co-culture of human bronchial fibroblasts and CD4+ T cells increases Th17 cytokine signature.

Authors:  Lionel Loubaki; Ikhlass Hadj-Salem; Raouia Fakhfakh; Eric Jacques; Sophie Plante; Marc Boisvert; Fawzi Aoudjit; Jamila Chakir
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

10.  IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells.

Authors:  Jill R Johnson; Michiyoshi Nishioka; Jamila Chakir; Paul-André Risse; Ibrahim Almaghlouth; Ahmad N Bazarbashi; Sophie Plante; James G Martin; David Eidelman; Qutayba Hamid
Journal:  Respir Res       Date:  2013-11-01
View more
  3 in total

1.  Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice.

Authors:  Lianlian Bian; Yu Bai; Fan Gao; Mingchen Liu; Qian He; Xing Wu; Qunying Mao; Miao Xu; Zhenglun Liang
Journal:  Virol J       Date:  2022-05-20       Impact factor: 5.913

2.  Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration.

Authors:  Xuehong Jia; Bo Liu; Linlin Bao; Qi Lv; Fengdi Li; Hui Li; Yunqing An; Xulong Zhang; Bin Cao; Chen Wang
Journal:  PLoS Pathog       Date:  2018-11-13       Impact factor: 6.823

3.  H1N1 influenza virus dose dependent induction of dysregulated innate immune responses and STAT1/3 activation are associated with pulmonary immunopathological damage.

Authors:  Duoduo Yao; Linlin Bao; Fengdi Li; Bo Liu; Xu Wu; Ziqi Hu; Jiangnan Xu; Wei Wang; Xulong Zhang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.